US$291,423
US$184,220
19.7%
US$126,801
US$46,631
US$11,515
-US$726
US$4,756
/yr
Portfolio
US Market
A past performer with good growth potential
14 holdings
14
Symbol | Price Vs Fair Value | 7D Return | Total Return | Value & Cost | Weight & Shares | Avg. Price | 1Y chart | |
---|---|---|---|---|---|---|---|---|
TSLA Tesla | US$339.03 169.9% overvalued intrinsic discount | 9.8% +US$3,031 | 53.4% +US$11,803 | US$33,903 US$22,100 | 11.6% 100 | US$221.00 | ||
PLTR Palantir Technologies | US$182.68 141.5% overvalued intrinsic discount | 5.4% +US$941 | 974.6% +US$16,568 | US$18,268 US$1,700 | 6.3% 100 | US$17.00 | ||
AMZN Amazon.com | US$221.30 19.8% undervalued intrinsic discount | 3.5% +US$430 | 59.4% +US$4,928 | US$12,614 US$7,775 | 4.3% 57 | US$136.41 | ||
BATS British American Tobacco | UK£43.14 32.1% undervalued intrinsic discount | 2.8% +US$1,090 | 43.8% +US$16,878 | US$40,549 US$26,990 | 13.9% 700 | UK£30.00 | ||
NVDA NVIDIA | US$182.06 58.2% overvalued intrinsic discount | 2.1% +US$152 | 879.4% +US$15,259 | US$7,282 US$1,443 | 2.5% 40 | US$36.06 | ||
JNJ Johnson & Johnson | US$173.82 28.6% undervalued intrinsic discount | 1.8% +US$154 | 83.4% +US$4,255 | US$8,691 US$5,100 | 3.0% 50 | US$102.00 | ||
BAC Bank of America | US$46.16 24.5% undervalued intrinsic discount | 1.3% +US$360 | 58.2% +US$11,116 | US$27,696 US$19,100 | 9.5% 600 | US$31.83 | ||
UNH UnitedHealth Group | US$252.37 70.9% undervalued intrinsic discount | 0.5% +US$27.40 | -37.5% -US$3,360 | US$5,047 US$8,960 | 1.7% 20 | US$448.00 | ||
META Meta Platforms | US$765.87 27.5% undervalued intrinsic discount | 0.3% +US$205 | 345.1% +US$54,727 | US$65,099 US$13,830 | 22.3% 85 | US$162.71 | ||
JPM JPMorgan Chase | US$289.56 16.8% undervalued intrinsic discount | -0.6% -US$90.50 | 44.4% +US$4,663 | US$14,478 US$10,500 | 5.0% 50 | US$210.00 | ||
XOM Exxon Mobil | US$105.83 56.7% undervalued intrinsic discount | -1.3% -US$289 | 90.9% +US$11,802 | US$21,695 US$12,897 | 7.4% 205 | US$62.91 | ||
CRWD CrowdStrike Holdings | US$426.43 2.3% undervalued intrinsic discount | -3.5% -US$766 | 53.2% +US$9,627 | US$21,322 US$13,100 | 7.3% 50 | US$262.00 | ||
OKTA Okta | US$88.51 31.6% undervalued intrinsic discount | -7.8% -US$598 | -55.7% -US$8,919 | US$7,081 US$16,000 | 2.4% 80 | US$200.00 | ||
TLX Telix Pharmaceuticals | AU$16.89 71.6% undervalued intrinsic discount | -8.9% -US$747 | 83.1% +US$6,084 | US$7,698 US$5,128 | 2.6% 700 | AU$11.00 |
There are three easy ways to get started:
Simply Wall St goes far beyond price tracking. You'll be able to:
Most brokers and portfolio trackers only show prices and unrealised gains, with little context and lots of noisy news. Simply Wall St offers:
In short, Simply Wall St is more than a tracker — it's a complete investing platform for monitoring, analysing, and growing your portfolio.
Have feedback on the portfolio tool?